Biota Pharmaceuticals Reports Second Quarter Fiscal Year 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall St set to snap three-day streak of losses despite Middle East clashes
- Oil rises, as US-Iran strikes risk limiting already impaired supplies
- Dell again lifts annual forecasts as AI demand powers record results
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
- Uber stock gains 2% as tech giant cuts 3,300 jobs in major restructuring
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Crude Inventory Fell 4.5M Barrels Last Week - EIA
- Google escapes ad tech breakup in third Big Tech antitrust loss for US
Biota Pharma (BOTA) Swings to Q2 Loss
February 5, 2016 7:06 AM ESTBiota Pharma (NASDAQ: BOTA) reported Q2 EPS of ($0.17), versus $0.19 reported last year. Revenue for the quarter came in at $1.7 million, versus $13.9 million reported last year.
For earnings history and earnings-related data on Biota Pharma (BOTA) click here.
... More